Modeling Hyperthermia-Enhanced Delivery of Doxorubicin in Solid Tumors
Mathematical modeling shows that timing hyperthermia with peak plasma TSL-DOX levels can double intracellular doxorubicin concentration.
Asset / Drug
Drug and asset intelligence for Modeling with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
Chemotherapy
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.